Abstract:Dysregulated lipid metabolism promotes the progression of various cancer types, including breast cancer. The present study aimed to explore the lipidomic profiles of patients with breast cancer, providing insights into the correlation between lipid compositions and tumor subtypes characterized by hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. Briefly, 30 patients with breast cancer were categorized into four groups based on their HR and HER2 status: HR+ no HER2 expression (HER2‐0), HR+ HER2‐low; HR+ HER2‐positive (pos) and HR‐ HER2‐pos. The lipidomic profiles of these patients were analyzed using high‐throughput liquid chromatography‐mass spectrometry. The data were processed through principal component analysis (PCA), partial least squares‐discriminant analysis (PLS‐DA) and random forest (RF) classification to assess the lipidomic variations and significant lipid features among these groups. The profiles of the lipids, particularly triglycerides (TG) such as TG(16:0‐18:1‐18:1)+NH4, were significantly different across the groups. PCA and PLS‐DA identified unique lipid profiles in the HR+ HER2‐pos and HR+ HER2‐0 groups, while RF highlighted phosphatidylinositol‐3,4,5‐trisphosphate(21:2)+NH4 as a crucial lipid feature for accurate patient grouping. Advanced statistical analysis showed significant correlations between lipid carbon chain length and the number of double bonds within the classifications, providing insights into the role of structural lipid properties in tumor biology. Additionally, a clustering heatmap and network analysis indicated significant lipid‐lipid interactions. Pathway enrichment analysis showed critical biological pathways, such as the 'Assembly of active LPL and LIPC lipase complexes', which has high enrichment ratio and statistical significance. In conclusion, the present study underscored that lipidomic profiling is crucial in understanding the metabolic alterations associated with different breast cancer subtypes. These findings highlighted specific lipid features and interactions that may serve as potential biomarkers for breast cancer classification and target pathways for therapeutic intervention. Furthermore, advanced lipidomic analyses can be integrated to decipher complex biological data, offering a foundation for further research into the role of lipid metabolism in cancer progression.

Enhanced Lipidomics Analysis of Breast Cancer Cells Using Three‐phase Liquid Extraction and Ultra High‐performance Liquid Chromatography Coupled With Quadrupole Time‐of‐Flight Tandem Mass Spectrometry

Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column.

Optimization of Lipid Extraction and Analytical Protocols for UHPLC-ESI-HRMS-based Lipidomic Analysis of Adherent Mammalian Cancer Cells

Determination of Lipid Mediators in Breast Cancer Cells Using Lyophilization-Supercritical Fluid Extraction Online Coupled with Supercritical Fluid Chromatography-Quadrupole Tandem Mass Spectrometry

Exploring lipidomic profiles and their correlation with hormone receptor and HER2 status in breast cancer

Single-cell Lipidomics with High Structural Specificity by Mass Spectrometry.

Metabolomics Analysis of Multidrug-Resistant Breast Cancer Cellsin Vitrousing Methyl-Tert-butyl Ether Method

Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers

Discovery of lipid profiles in plasma‐derived extracellular vesicles as biomarkers for breast cancer diagnosis

Matrix-assisted laser desorption/ionization mass spectrometry imaging of cell cultures for the lipidomic analysis of potential lipid markers in human breast cancer invasion

Mass Spectrometry (LC–MS/MS) Identified Proteomic Biosignatures of Breast Cancer in Proximal Fluid

Efficient Serum Lipids Profiling by TiO2-dopamin-assisted MALDI-TOF MS for Breast Cancer Detection

Mass Spectrometry-Based Quantitative Metabolomics Revealed A Distinct Lipid Profile In Breast Cancer Patients

A Novel Online Two-Dimensional Supercritical Fluid Chromatography/reversed Phase Liquid Chromatography–mass Spectrometry Method for Lipid Profiling

Sequential Detection of Lipids, Metabolites and Proteins in One Tissue for Improved Cancer Differentiation Accuracy.

“Modeling−Prediction” Strategy for Deep Profiling of Lysophosphatidic Acids by Liquid Chromatography−Mass Spectrometry: Exploration Biomarkers of Breast Cancer

Comprehensive Serum Lipidomic Analyses Reveal Potential Biomarkers for Malignant Breast Cancer: A Case-Control Study.

Plasma Lipidomics Profiling Identified Lipid Biomarkers In Distinguishing Early-Stage Breast Cancer From Benign Lesions

Selective detection of phospholipids in human blood plasma and single cells for cancer differentiation using dispersed solid-phase microextraction combined with extractive electrospray ionization mass spectrometry

Deep mining and quantification of oxidized cholesteryl esters discovers potential biomarkers involved in breast cancer by liquid chromatography-mass spectrometry

Direct Analysis of Phospholipids in Biological Tissues Using Internal Extractive Electrospray Ionization Mass Spectrometry